Previous Chapter: 4. New Developments Affecting the Industry
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 77
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 78
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 79
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 80
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 81
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 82
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 83
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 84
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 85
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 86
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 87
Suggested Citation: "5. Options for American Industrial Policy." National Research Council. 1983. The Competitive Status of the U.S. Pharmaceutical Industry: The Influences of Technology in Determining International Industrial Competitive Advantage. Washington, DC: The National Academies Press. doi: 10.17226/156.
Page 88
Next Chapter: Biographical Sketches
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.